Peter R. Paradiso

4.9k total citations · 1 hit paper
56 papers, 4.0k citations indexed

About

Peter R. Paradiso is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Peter R. Paradiso has authored 56 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 19 papers in Infectious Diseases and 13 papers in Microbiology. Recurrent topics in Peter R. Paradiso's work include Respiratory viral infections research (30 papers), Pneumonia and Respiratory Infections (23 papers) and Bacterial Infections and Vaccines (13 papers). Peter R. Paradiso is often cited by papers focused on Respiratory viral infections research (30 papers), Pneumonia and Respiratory Infections (23 papers) and Bacterial Infections and Vaccines (13 papers). Peter R. Paradiso collaborates with scholars based in United States, Estonia and Italy. Peter R. Paradiso's co-authors include George R. Siber, William P. Hausdorff, John Bryant, Stuart S. Levine, Irwin Singer, S L Rhode, Ih Chang, DEBORAH A. HOGERMAN, Dace V. Madore and S HILDRETH and has published in prestigious journals such as Cell, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Peter R. Paradiso

56 papers receiving 3.7k citations

Hit Papers

Which Pneumococcal Serogroups Cause the Most Invasive Dis... 2000 2026 2008 2017 2000 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I
    2000 694 citations William P. Hausdorff, John Bryant et al. Clinical Infectious Diseases profile →

Peers

Peter R. Paradiso
R L Horswood United States
Michel Klein Canada
Tetsuo Nakayama Japan
James A. Williams United States
P. J. Watt United Kingdom
Stig Jeansson Sweden
R. Michael Hendry United States
Akira Nishizono Japan
R. Jennings United Kingdom
Edward B. Kaczmarski United Kingdom
R L Horswood United States
Peter R. Paradiso
Citations per year, relative to Peter R. Paradiso Peter R. Paradiso (= 1×) peers R L Horswood

Countries citing papers authored by Peter R. Paradiso

Since Specialization
Citations

This map shows the geographic impact of Peter R. Paradiso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Paradiso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Paradiso more than expected).

Fields of papers citing papers by Peter R. Paradiso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Paradiso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Paradiso. The network helps show where Peter R. Paradiso may publish in the future.

Co-authorship network of co-authors of Peter R. Paradiso

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Paradiso. A scholar is included among the top collaborators of Peter R. Paradiso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Paradiso. Peter R. Paradiso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Istúriz, Raúl, Beate Schmöele-Thoma, Daniel A. Scott, et al.. (2015). Pneumococcal conjugate vaccine use in adults. Expert Review of Vaccines. 15(3). 279–293. 15 indexed citations
2.
Rodgers, Gail L., Susanna Esposito, Nicola Principi, et al.. (2013). Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule. Vaccine. 31(42). 4765–4774. 16 indexed citations
3.
Paradiso, Peter R.. (2011). Advances in Pneumococcal Disease Prevention: 13-Valent Pneumococcal Conjugate Vaccine for Infants and Children. Clinical Infectious Diseases. 52(10). 1241–1247. 48 indexed citations
4.
Hausdorff, William P., George R. Siber, & Peter R. Paradiso. (2001). Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. The Lancet. 357(9260). 950–952. 170 indexed citations
5.
Paradiso, Peter R.. (2001). Maternal immunization: the influence of liability issues on vaccine development. Vaccine. 20. S73–S74. 10 indexed citations
6.
Hausdorff, William P., et al.. (2000). The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II. Clinical Infectious Diseases. 30(1). 122–140. 283 indexed citations
7.
Hausdorff, William P., John Bryant, Peter R. Paradiso, & George R. Siber. (2000). Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I. Clinical Infectious Diseases. 30(1). 100–121. 694 indexed citations breakdown →
8.
Shinefield, Henry R., Steven Black, Paula Ray, et al.. (1999). Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. The Pediatric Infectious Disease Journal. 18(9). 757–763. 234 indexed citations
9.
Paradiso, Peter R.. (1996). The future of polio immunization in the United States: are we ready for change?. The Pediatric Infectious Disease Journal. 15(8). 645–649. 11 indexed citations
10.
Vitolo, Domenico, Peter R. Paradiso, Stefania Uccini, Luigi Ruco, & Carlo Baroni. (1996). Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: relation to angiogenesis and spread. Histopathology. 28(6). 521–528. 46 indexed citations
11.
Paradiso, Peter R.. (1995). Combination Vaccines for Diphtheria, Tetanus, Pertussis, and Haemophilus influenzae Type b. Annals of the New York Academy of Sciences. 754(1). 108–113. 9 indexed citations
12.
Paradiso, Peter R., Stephen W. Hildreth, DEBORAH A. HOGERMAN, et al.. (1994). Safety and immunogenicity of a subunit respiratory syncytial virus vacine in children 24 to 48 months old. The Pediatric Infectious Disease Journal. 13(9). 792–797. 71 indexed citations
13.
Tristram, Debra, et al.. (1993). Immunogenicity and Safety of Respiratory Syncytial Virus Subunit Vaccine in Seropositive Children 18-36 Months Old. The Journal of Infectious Diseases. 167(1). 191–195. 103 indexed citations
14.
15.
Paradiso, Peter R., Branda Hu, Rasappa Arumugham, & Stephen W. Hildreth. (1991). Mapping of a fusion related epitope of the respiratory syncytial virus fusion protein. Vaccine. 9(4). 231–237. 6 indexed citations
16.
Martín-Gallardo, Antonia, R A Deich, Karen Fien, et al.. (1989). Alkaline Phosphatase Fusions to the Respiratory Syncytial Virus F Protein as an Approach to Analyze Its Membrane Topology. DNA. 8(9). 659–667. 3 indexed citations
17.
Arumugham, Rasappa, Stephen W. Hildreth, & Peter R. Paradiso. (1989). Interprotein disulfide bonding between F and G glycoproteins of human respiratory syncytial virus. Archives of Virology. 105(1-2). 65–79. 11 indexed citations
18.
Walsh, Edward E., Charles B. Hall, J. J. Schlesinger, et al.. (1989). Comparison of Antigenic Sites of Subtype-specific Respiratory Syncytial Virus Attachment Proteins. Journal of General Virology. 70(11). 2953–2961. 43 indexed citations
19.
20.
Paradiso, Peter R., et al.. (1989). Antigenic Structure of the Fusion Glycoprotein of Respiratory Syncytial Virus. PubMed. 251. 273–278. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R L Horswood Breakdown of academic impact, for papers by Michel Klein Breakdown of academic impact, for papers by Tetsuo Nakayama Breakdown of academic impact, for papers by James A. Williams Breakdown of academic impact, for papers by P. J. Watt Breakdown of academic impact, for papers by Stig Jeansson Breakdown of academic impact, for papers by R. Michael Hendry Breakdown of academic impact, for papers by Akira Nishizono Breakdown of academic impact, for papers by R. Jennings Breakdown of academic impact, for papers by Edward B. Kaczmarski
Rankless by CCL
2026